1. Home
  2. CERS vs CRNT Comparison

CERS vs CRNT Comparison

Compare CERS & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • CRNT
  • Stock Information
  • Founded
  • CERS 1991
  • CRNT 1996
  • Country
  • CERS United States
  • CRNT Israel
  • Employees
  • CERS N/A
  • CRNT N/A
  • Industry
  • CERS EDP Services
  • CRNT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • CERS Technology
  • CRNT Technology
  • Exchange
  • CERS Nasdaq
  • CRNT Nasdaq
  • Market Cap
  • CERS 347.3M
  • CRNT 303.2M
  • IPO Year
  • CERS 1997
  • CRNT 2000
  • Fundamental
  • Price
  • CERS $1.65
  • CRNT $3.01
  • Analyst Decision
  • CERS Buy
  • CRNT Strong Buy
  • Analyst Count
  • CERS 3
  • CRNT 4
  • Target Price
  • CERS $3.17
  • CRNT $6.44
  • AVG Volume (30 Days)
  • CERS 1.6M
  • CRNT 2.7M
  • Earning Date
  • CERS 02-20-2025
  • CRNT 02-11-2025
  • Dividend Yield
  • CERS N/A
  • CRNT N/A
  • EPS Growth
  • CERS N/A
  • CRNT 285.71
  • EPS
  • CERS N/A
  • CRNT 0.27
  • Revenue
  • CERS $180,270,000.00
  • CRNT $394,190,000.00
  • Revenue This Year
  • CERS $15.95
  • CRNT $5.00
  • Revenue Next Year
  • CERS $10.50
  • CRNT $5.72
  • P/E Ratio
  • CERS N/A
  • CRNT $11.15
  • Revenue Growth
  • CERS 15.29
  • CRNT 13.54
  • 52 Week Low
  • CERS $1.38
  • CRNT $2.33
  • 52 Week High
  • CERS $2.59
  • CRNT $5.73
  • Technical
  • Relative Strength Index (RSI)
  • CERS 41.40
  • CRNT 28.73
  • Support Level
  • CERS $1.64
  • CRNT $3.43
  • Resistance Level
  • CERS $1.96
  • CRNT $3.54
  • Average True Range (ATR)
  • CERS 0.11
  • CRNT 0.31
  • MACD
  • CERS -0.02
  • CRNT -0.17
  • Stochastic Oscillator
  • CERS 3.12
  • CRNT 0.40

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About CRNT Ceragon Networks Ltd.

Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and global distribution of its business, providing high-capacity wireless connectivity solutions to global markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the major revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.

Share on Social Networks: